Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β

scientific article published on 05 September 2019

Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/CIRCULATIONAHA.119.040366
P932PMC publication ID6784777
P698PubMed publication ID31567019

P50authorEnrique Lara-PezziQ38362058
Jesús VázquezQ56527657
Fernando DominguezQ57082157
Giovanna GiovinazzoQ57322656
Fernando MartinezQ58330202
María Villalba OreroQ84348345
P2093author name stringMaría Victoria Gómez-Gaviro
Elena Bonzón-Kulichenko
Laura Padrón-Barthe
Marta Román
Silvia Priori
Pablo Garcia-Pavia
Belén Prados
Carlos Martí-Gómez
Demetrio J Santiago
Jesús M Gómez-Salinero
Javier Larrasa-Alonso
Paula Ortiz-Sánchez
Marina López-Olañeta
P2860cites workTMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathyQ24296250
Ebp1 isoforms distinctively regulate cell survival and differentiationQ24296796
LUMA interacts with emerin and influences its distribution at the inner nuclear membraneQ24308392
Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathyQ24548702
Nuclear envelope proteomics: novel integral membrane proteins of the inner nuclear membraneQ24555150
De novo cardiomyocytes from within the activated adult heart after injuryQ24605971
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 geneQ24656100
Autophagy in cardiovascular biologyQ26866165
Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifsQ28119049
Nuclear membrane proteins with potential disease links found by subtractive proteomicsQ28205222
Histological and ultrastructural abnormalities in murine desmoglein 2-mutant heartsQ28258584
Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNaseQ28568026
Mimicking Cardiac Fibrosis in a Dish: Fibroblast Density Rather than Collagen Density Weakens Cardiomyocyte FunctionQ33705089
Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivoQ33954489
Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathyQ34212672
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesisQ34316944
Protein LUMA is a cytoplasmic plaque constituent of various epithelial adherens junctions and composite junctions of myocardial intercalated disks: a unifying finding for cell biology and cardiology.Q34417359
Therapy of experimental NASH and fibrosis with galectin inhibitorsQ35075568
Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study.Q36131473
Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt/β-catenin signalingQ36699635
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathyQ36884231
Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overloadQ37081700
Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation OutcomesQ37164851
Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.Q37259910
Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathyQ37292752
Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse modelQ37572134
Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injuryQ37758529
Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexesQ38346878
Animal models of arrhythmogenic right ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeuticsQ39422223
Calcineurin splicing variant calcineurin Aβ1 improves cardiac function after myocardial infarction without inducing hypertrophy.Q39743659
Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator TherapyQ39929877
A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regenerationQ40034287
The Calcineurin Variant CnAβ1 Controls Mouse Embryonic Stem Cell Differentiation by Directing mTORC2 Membrane Localization and ActivationQ46696038
Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.Q47108829
MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo.Q47241525
Luma is not essential for murine cardiac development and function.Q47639598
Arrhythmogenic Right Ventricular Cardiomyopathy.Q52932634
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.Q55638651
Cardiac-Specific Loss of N-Cadherin Leads to Alteration in Connexins With Conduction Slowing and ArrhythmogenesisQ57396516
Induction of the calcineurin variant CnAβ1 after myocardial infarction reduces post-infarction ventricular remodelling by promoting infarct vascularizationQ57761226
The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43Q57901761
The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug TestingQ88913236
P433issue14
P921main subjectarrhythmogenic right ventricular cardiomyopathyQ2555727
P304page(s)1188-1204
P577publication date2019-09-05
P1433published inCirculationQ578091
P1476titleSevere Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β
P478volume140